Bulletin
Investor Alert

New York Markets Open in:

Company Close Updates

Dec. 6, 2021, 4:31 p.m. EST

Moderna Inc. stock underperforms Monday when compared to competitors

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) plunged 13.49% to $265.33 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) rising 0.93% to 15,225.15 and the Dow Jones Industrial Average (DOW:DJIA) rising 1.87% to 35,227.03. Moderna Inc. closed $232.16 short of its 52-week high ($497.49), which the company reached on August 10th.

The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (NYS:ABBV) rose 2.10% to $121.35, Amgen Inc. (NAS:AMGN) rose 3.14% to $208.79, and AstraZeneca PLC ADR (NAS:AZN) rose 2.18% to $55.41. Trading volume (19.7 M) eclipsed its 50-day average volume of 13.3 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.